SEC Form 4 · accession 0000899243-18-023861
CONSTELLATION PHARMACEUTICALS INC · CNST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven L. Hoerter
Director
Period of report
Sep 4, 2018
Accepted (ET)
Sep 5, 2018 · 5:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $9.05 | Sep 4, 2018 | A | 26,342 | A | — | Sep 3, 2028 | Common Stock | 26,342 | 26,342 | D |
Explanation of responses
- F1This option was granted on September 4, 2018 and is scheduled to vest in equal monthly installments through September 4, 2021, subject to continued service.